Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
13
ATRC Quote, Financials, Valuation and Earnings
Last price:
$33.25
Seasonality move
:
1.94%
Day range:
$32.00 - $33.11
52-week range:
$28.29 - $43.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.89x
P/B ratio:
3.38x
Volume:
847.8K
Avg. volume:
755.3K
1-year change:
-17%
Market cap:
$1.6B
Revenue:
$534.5M
EPS (TTM):
-$0.24
Analysts' Opinion
-
Consensus RatingAtriCure, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $48.78, AtriCure, Inc. has an estimated upside of 50.64% from its current price of $32.38.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $36.00 representing -11.18% downside risk from its current price of $32.38.
Fair Value
-
According to the consensus of 6 analysts, AtriCure, Inc. has 50.64% upside to fair value with a price target of $48.78 per share.
ATRC vs. S&P 500
-
Over the past 5 trading days, AtriCure, Inc. has underperformed the S&P 500 by -1.94% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
AtriCure, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AtriCure, Inc. has grown year-over-year revenues for 20 quarters straight. In the most recent quarter AtriCure, Inc. reported revenues of $140.5M.
Earnings Growth
-
AtriCure, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter AtriCure, Inc. reported earnings per share of $0.04.
Enterprise value:
1.5B
EV / Invested capital:
2.67x
Price / LTM sales:
2.89x
EV / EBIT:
--
EV / Revenue:
2.84x
PEG ratio (5yr expected):
-31.34x
EV / Free cash flow:
47.57x
Price / Operating cash flow:
49.08x
Enterprise value / EBITDA:
140.78x
Gross Profit (TTM):
$403.6M
Return On Assets:
-1.85%
Net Income Margin (TTM):
-2.14%
Return On Equity:
-2.44%
Return On Invested Capital:
-2.09%
Operating Margin:
1.77%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $399.2M | $465.3M | $534.5M | $124.3M | $140.5M | |
| Gross Profit | $298.9M | $344.5M | $403.6M | $91.9M | $110.4M | |
| Operating Income | -$31.8M | -$28M | -$4.4M | -$2.5M | $2.5M | |
| EBITDA | -$16.9M | -$9.3M | -- | $2.3M | -- | |
| Diluted EPS | -$0.66 | -$0.95 | -$0.24 | -$0.33 | $0.04 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $196.1M | $215.2M | $266.2M | $267.8M | $322.5M | |
| Total Assets | $615.3M | $585.4M | $613.9M | $609.3M | $654.2M | |
| Current Liabilities | $56.4M | $58.4M | $74.6M | $73.4M | $81.5M | |
| Total Liabilities | $131.6M | $128.7M | $147.8M | $148.4M | $162.2M | |
| Total Equity | $483.8M | $456.8M | $466.2M | $461M | $491.9M | |
| Total Debt | $74.8M | $70.1M | $73M | $74.9M | $73.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $440K | $10.4M | $42.1M | $20M | $26.7M | |
| Cash From Investing | $31.6M | $42.1M | -$26.6M | $4.4M | -$2.6M | |
| Cash From Financing | -$349K | -$3M | $1.9M | -$333K | $6M | |
| Free Cash Flow | -$42.9M | -$1.2M | $31.9M | $16.4M | $24.1M | |
ATRC
Sector
Market Cap
$1.6B
$25.2M
Price % of 52-Week High
74.99%
49.83%
Dividend Yield
0%
0%
Shareholder Yield
0.33%
-1.77%
1-Year Price Total Return
-17%
-21.9%
Beta (5-Year)
1.415
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$33.72
200-day SMA
Sell
Level
$35.22
Bollinger Bands (100)
Sell
Level
33.88 - 39.76
Chaikin Money Flow
Buy
Level
30.3M
20-day SMA
Sell
Level
$36.12
Relative Strength Index (RSI14)
Sell
Level
35.16
ADX Line
Sell
Level
24.67
Williams %R
Neutral
Level
-73.7925
50-day SMA
Sell
Level
$38.59
MACD (12, 26)
Sell
Level
-1.71
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
49.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.6007)
Buy
CA Score
(Annual)
Level (0.9667)
Buy
Beneish M-Score
(Annual)
Level (-2.7959)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.4695)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Stock Forecast FAQ
In the current month, ATRC has received 4 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ATRC average analyst price target in the past 3 months is $48.78.
-
Where Will AtriCure, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that AtriCure, Inc. share price will rise to $48.78 per share over the next 12 months.
-
What Do Analysts Say About AtriCure, Inc.?
Analysts are divided on their view about AtriCure, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AtriCure, Inc. is a Sell and believe this share price will drop from its current level to $36.00.
-
What Is AtriCure, Inc.'s Price Target?
The price target for AtriCure, Inc. over the next 1-year time period is forecast to be $48.78 according to 6 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ATRC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AtriCure, Inc. is a Buy. 4 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ATRC?
You can purchase shares of AtriCure, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AtriCure, Inc. shares.
-
What Is The AtriCure, Inc. Share Price Today?
AtriCure, Inc. was last trading at $33.25 per share. This represents the most recent stock quote for AtriCure, Inc.. Yesterday, AtriCure, Inc. closed at $32.38 per share.
-
How To Buy AtriCure, Inc. Stock Online?
In order to purchase AtriCure, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ATRC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ATRC
Sector
P/E ratio
--
23.30x
PEG ratio
-31.34x
-0.01x
P/B ratio
3.38x
1.78x
Price / LTM sales
2.89x
1.55x
Growth Metrics
ATRC
Sector
Revenue growth
13.05%
3.69%
Earnings growth
111.08%
9.95%
Revenue (5-year growth)
20.95%
6.38%
Earnings forecast
-$0.04
-$0.19
Profitability
ATRC
Sector
Profitability FY 2025
$421.3M
$2.6M
Return on invested capital
-2.09%
-33.25%
Return on assets
-1.85%
-29.67%
Return on equity
-2.44%
-38.66%
Earnings Date
Last Earnings Date
Feb
17
Next Earnings Date
Apr
28
Estimated Next Earnings Date
May
19
Balance Sheet
ATRC
Sector
Total cash
$167.4M
$25.1M
Short term investments
--
$24M
Total assets
$654.2M
$72.5M
Long term debt
$73.4M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
23
CAR alert for Feb 20
Avis Budget Group, Inc. [CAR] is down 1.72% over the past day.
Buy
75
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is up 0.31% over the past day.
Sell
1
EPAM alert for Feb 20
EPAM Systems, Inc. [EPAM] is up 0.21% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
